Rationally designed modular STAT-activating scaffolds enforce cell-intrinsic transcriptional programs augmenting the anti-tumor potency of CAR T cells
C. P. Saxby, T. K. Ishida, J. M. Rosser, B. C. Curtis, M. L. Baldwin, C. H. Spurrell, J. Giles, A. Valdez, A. J. Johnson, J. Gustafson, J. S. Appelbaum, M. C. Jensen
This study designs and tests STAT-activating scaffolds to enhance CAR T cell anti-tumor potency, finding that LASI-3 improves function without lymphoproliferative side effects.
bioRxiv · Dec 22, 2023 · PreprintBioengineering